Outsourced Pharma Webinars

  1. From Brick Dust To Breakthrough: The Power Of Enabled Formulation 2/26/2026

    Enabled formulation strategies transform poorly soluble, highly lipophilic molecules into viable oral products by improving exposure, reducing burden, and ensuring manufacturable pathways.

  2. From Molecule To Milestone: Fast Track Formulation 2/26/2026

    Fast‑track, data‑driven formulation strategies align early decisions with long‑term goals, enabling First‑in‑Human progress while reducing risk, avoiding rework, and supporting manufacturable development.

  3. Navigating Complexity: Tailored Analytical & Preclinical Services 2/26/2026

    Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.

  4. Inside AustinPx: Live Company Overview 2/26/2026

    An inside look at a development partner's approach to guiding drug programs, using advanced formulation technology and integrated services to support scalable, high‑performance oral dosage development.

  5. Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields 2/26/2026

    Explore how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.

  6. Integrated Thinking for Complex FIH Programs 2/25/2026

    See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.

  7. Revolutionizing Gene Therapy Manufacturing: Robotics, ML For Process Intensification 2/25/2026

    By integrating perfusion into upstream manufacturing, see how this approach has achieved up to a fivefold increase in productivity, delivering titers that significantly exceed current industry benchmarks.

  8. Using Rapid Development Framework™ To Accelerate CGT Development, Manufacturing 2/25/2026

    Learn how the following framework can accelerate your viral vector, CAR-T, and iPSC programs, reduce risk, and streamline your path from development to commercial manufacturing.

  9. Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs 2/23/2026

    Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.

  10. Beyond Solid Phase Synthesis 2/12/2026

    Explore how enzymatic methods, real-time analytics, and AI optimization enhance long-sequence TIDES, improving control, speeding timelines, and supporting sustainable production.